Call for Collaboration / Partnership

PhaRNA, LLC is looking for academic and industry collaborators and partners to co-develop RNA-based therapeutics including vaccines for the prevention or treatment of microbial diseases caused by parasites, fungi, viruses and bacteria. Our company’s proprietary technology has the versatility of rapidly designing RNA-based products for testing and development in preclinical and clinical settings. More specifically, we are looking for potential collaborators and partners who have the capacity to take our custom-designed RNA products and test their efficacy using molecular, cell biological and animal models. We will then partner to develop the most promising drug candidates through early phase clinical studies. We believe that this form of collaboration will capitalize on the strengths of PhaRNA, LLC and the partnering organization to rapidly test and develop potentially life-saving drugs and vaccines. Some of the microbial infections that we are looking to find collaborators/partners are:

  • Coronaviruses
  • Human Immunodeficiency Virus (HIV)
  • Influenza virus
  • Norovirus
  • Ebola virus
  • West Nile virus
  • Dengue virus
  • Zika virus
  • Herpes Simplex Virus (HSV)
  • Hepatitis C Virus (HCV)
  • Cytomegalovirus (CMV)
  • Human Papilloma Virus (HPV)
  • Helicobacter pylori (H. pylori)
  • Staphylococcus aureus (S. aureus)
  • Pseudomonas aeruginosa (P. aeruginosa)
  • Neisseria gonorrhea (N. gonorrhea)
  • Listeria monocytogenes (L. monocytogenes)
  • Schistosomia mansoni (S. mansoni)
  • Candida albicans (C. albicans)

If you are interested in collaborating in any of the infectious diseases projects described above or if you have specific projects that are not listed here, please contact us directly.